106 related articles for article (PubMed ID: 2322928)
1. Oxidation of 2-amino-9-beta-D-ribofuranosylpurine-6-sulfenamide to the corresponding 6-sulfonamide facilitates changes in biologic characterization that include activity against thiopurine-refractory experimental leukemia.
Finch RA; Vasquez KM; Hanna NB; Revankar GR; Robins RK; Avery TL
Cancer Lett; 1990 Apr; 50(1):63-70. PubMed ID: 2322928
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vivo antitumor activity of 2-amino-9H-purine-6-sulfenamide, -sulfinamide, and -sulfonamide and related purine ribonucleosides.
Revankar GR; Hanna NB; Imamura N; Lewis AF; Larson SB; Finch RA; Avery TL; Robins RK
J Med Chem; 1990 Jan; 33(1):121-8. PubMed ID: 2296010
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutic characterization in mice of 2-amino-9-beta-D-ribofuranosylpurine-6-sulfinamide (sulfinosine), a novel purine nucleoside with unique antitumor properties.
Avery TL; Finch RA; Vasquez KM; Radparvar S; Hanna NB; Revankar GR; Robins RK
Cancer Res; 1990 May; 50(9):2625-30. PubMed ID: 2328488
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor evaluation in mice of certain 7-deazapurine (pyrrolo[2,3-d]pyrimidine) and 3-deazapurine (imidazo[4,5-c]pyridine) nucleosides structurally related to sulfenosine, sulfinosine, and sulfonosine.
Ramasamy K; Imamura N; Hanna NB; Finch RA; Avery TL; Robins RK; Revankar GR
J Med Chem; 1990 Apr; 33(4):1220-5. PubMed ID: 2319564
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the in vitro antitumor activity of novel purine-6-sulfenamide, -sulfinamide, and -sulfonamide nucleosides and certain related compounds using a computer-aided receptor modeling procedure.
Viswanadhan VN; Ghose AK; Hanna NB; Matsumoto SS; Avery TL; Revankar GR; Robins RK
J Med Chem; 1991 Feb; 34(2):526-32. PubMed ID: 1995873
[TBL] [Abstract][Full Text] [Related]
6. Sulfinosine congeners: synthesis and antitumor activity in mice of certain N9-alkylpurines and purine ribonucleosides.
Hanna NB; Bhattacharya BK; Robins RK; Avery TL; Revankar GR
J Med Chem; 1994 Jan; 37(1):177-83. PubMed ID: 8289192
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1-deaza-6-thioguanosine and 1-deaza-6-(methylthio)guanosine.
Elliott RD; Montgomery JA
J Med Chem; 1978 Jan; 21(1):112-4. PubMed ID: 619139
[TBL] [Abstract][Full Text] [Related]
8. Potential antitumor agents. Some sulfur-substituted derivatives of alpha- and beta-2'-deoxythioguanosine.
Martinez AP; Lee WW; Henry DW
J Med Chem; 1977 Mar; 20(3):341-4. PubMed ID: 845866
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of 7- and 9-(6'-deoxy-alpha-L-talofuranosyl) hypoxanthine and 9-(6'-deoxy-alpha-L-talofuranosyl)-6-thiopurine.
Nelson V; El Khadem HS
J Med Chem; 1983 Oct; 26(10):1527-30. PubMed ID: 6684690
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of hypoxanthine, guanine, and 6-thiopurine nucleosides of 6-deoxy-D-allofuranose.
Nelson V; El Khadem HS; Whitten BK; Sesselman D
J Med Chem; 1983 Jul; 26(7):1071-4. PubMed ID: 6864734
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative activity of purine nucleoside dialdehydes against leukemia L1210 in vitro.
Sheid B; Saggar M; Gaetjens E; Lerner LM
Cancer Chemother Pharmacol; 1991; 28(5):339-43. PubMed ID: 1914076
[TBL] [Abstract][Full Text] [Related]
12. Combinational chemotherapy of L1210 and L1210/ARA-C leukemia with 5-AZA-2'-deoxycytidine and beta-2'-deoxythioguanosine.
Momparler RL; Momparler LF; Samson J
Int J Cancer; 1982 Sep; 30(3):361-64. PubMed ID: 6182115
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiviral evaluation of carbocyclic analogues of ribofuranosides of 2-amino-6-substituted-purines and of 2-amino-6-substituted-8-azapurines.
Shealy YF; Clayton JD; Arnett G; Shannon WM
J Med Chem; 1984 May; 27(5):670-4. PubMed ID: 6325694
[TBL] [Abstract][Full Text] [Related]
14. Proceedings: Discussion of pattern recognition.
Unger SH
Cancer Chemother Rep 2; 1974 Dec; 4(4):45-6. PubMed ID: 4475613
[No Abstract] [Full Text] [Related]
15. Combination therapy of mouse leukemia L1210 by 1-beta-D-arabinofuranosylcytosine and 6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine.
Cass CE; Muzik H; Paterson AR
Cancer Res; 1975 May; 35(5):1187-93. PubMed ID: 1120308
[TBL] [Abstract][Full Text] [Related]
16. Preparation and biological activity of 5,6-dihydro-5-azapyrimidine nucleosides.
Pískala A; Cesneková B; Veselý J
Nucleic Acids Symp Ser; 1987; (18):57-60. PubMed ID: 3697151
[TBL] [Abstract][Full Text] [Related]
17. Synthetic approaches to the guanosine and xanthosine analogues 5-amino-3-beta-D-ribofuranosylpyrazolo[3,4-e][1,3]oxazin-7-one and 3-beta-D-ribofuranosylpyrazolo[3,4-e][1,3]oxazine-5,7-dione and studies of their antitumor potential.
Zou RM; Beylin VG; Groziak MP; Wotring LL; Townsend LB
J Med Chem; 1991 Jul; 34(7):1951-9. PubMed ID: 2066967
[TBL] [Abstract][Full Text] [Related]
18. 2'-fluorinated pyrimidine isonucleosides. Novel nucleoside analogs demonstrate therapeutic activity in mice with tumors.
Bobek M; An SH; Skrincosky D; De Clerq E; Bernacki RJ
Nucleic Acids Symp Ser; 1987; (18):5-7. PubMed ID: 3697150
[No Abstract] [Full Text] [Related]
19. Synthesis and antiviral activity of certain 9-beta-D-ribofuranosylpurine-6-carboxamides.
Westover JD; Revankar GR; Robins RK; Madsen RD; Ogden JR; North JA; Mancuso RW; Rousseau RJ; Stephen EL
J Med Chem; 1981 Aug; 24(8):941-6. PubMed ID: 7328597
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiviral activity of certain guanosine analogues in the thiazolo[4,5-d]pyrimidine ring system.
Kini GD; Anderson JD; Sanghvi YS; Lewis AF; Smee DF; Revankar GR; Robins RK; Cottam HB
J Med Chem; 1991 Oct; 34(10):3006-10. PubMed ID: 1656042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
